Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has maintained its Overweight rating on Regeneron Pharmaceuticals, Inc. (NASDAQ ...

Regeneron Pharmaceuticals (NASDAQ:REGN) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments ...

On Tuesday, Morgan Stanley (NYSE: MS) adjusted its outlook on Regeneron (NASDAQ: REGN) Pharmaceuticals stock, reducing the price target from $1,185.00 to $1,150.00.Despite the decrease, the firm ...

Deciphering Analyst Ratings: An In-Depth Analysis A clear picture of Regeneron Pharmaceuticals's perception among financial experts is painted with a thorough analysis of recent analyst actions.

On Monday, Truist Securities confirmed its positive stance on Regeneron (NASDAQ: REGN) Pharmaceuticals, maintaining a Buy rating and a $1,004.00 price target for the company's stock.The stock, ...

JPMorgan lowered the firm’s price target on Regeneron (REGN ... particularly as we near a number of pipeline readouts, the analyst tells investors in a research note. Published first on TheFly ...